FYR Diagnostics
- Diagnostics
- Synthesis, analytic, diagnostic services
- Other products or services
- Other R&D services
- Biotech or pharma, therapeutic R&D
FYR is developing the next generation of liquid biopsy solutions to meet currently unmet diagnostic needs by unlocking the power of disease-derived Extracellular Vesicles (EVs) for the detection, profiling, and monitoring of disease.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}